Abstract CD4 + CD25 + regulatory T cells (Tregs) exert a suppressive activity on atherosclerosis but the underlying mechanism remains unclear. Here, we investigated whether and how Tregs affect oxLDLinduced proinflammatory response in macrophages. Tregs were isolated by magnetic cell sorting-column and analyzed by flow cytometry. Macrophages were cultured with or without Tregs in the presence of oxLDL for 48 hours to induce proinflammatory response. Our data showed that with oxLDL challenge, the Tregmodulated macrophages have decreased NO production and iNOS expression, decreased HLA-DR and CD86 expression, and down-regulated proinflammatory cytokine/chemokine production. Tregs can inhibit the pro-inflammatory properties of macrophages and steer macrophage differentiation toward an anti-inflammatory cytokine producing phenotype. Mechanistic studies reveal that Tregmediated suppression of the monocyte response to oxLDL was reflected by a reduction in the upregulation of NF-κB activity accompanied by a decreased expression of TLR2 but not TLR4 at the transcriptional level. These results suggest that CD4 + CD25 + Foxp3 + regulatory T cells may exert its suppressive functions on pro-inflammatory properties of OxLDL induced-macrophages partly through TLR2-NF-κB signaling pathway.
regulatory T cells (Tregs) exert a suppressive activity on atherosclerosis but the underlying mechanism remains unclear. Here, we investigated whether and how Tregs affect oxLDLinduced proinflammatory response in macrophages. Tregs were isolated by magnetic cell sorting-column and analyzed by flow cytometry. Macrophages were cultured with or without Tregs in the presence of oxLDL for 48 hours to induce proinflammatory response. Our data showed that with oxLDL challenge, the Tregmodulated macrophages have decreased NO production and iNOS expression, decreased HLA-DR and CD86 expression, and down-regulated proinflammatory cytokine/chemokine production. Tregs can inhibit the pro-inflammatory properties of macrophages and steer macrophage differentiation toward an anti-inflammatory cytokine producing phenotype. Mechanistic studies reveal that Tregmediated suppression of the monocyte response to oxLDL was reflected by a reduction in the upregulation of NF-κB activity accompanied by a decreased expression of TLR2 but not TLR4 at the transcriptional level. These results suggest that CD4 + CD25 +
Foxp3

Introduction
Atherosclerosis starts with an innate immune response involving the recruitment and activation of monocytes/macrophages that respond to an excessive accumulation of modified lipids within the arterial wall, followed by an adaptive immune response involving antigen-specific T lymphocytes [1] [2] . Effector T cells recognize modified auto-antigens such as ox-LDL and heat shock proteins (i.e. HSP-60) that are presented by antigen-presenting cells such as macrophages or dendritic cells [3] . The accumulation of inflammatory cells within the arterial wall leads to local production of chemokines, interleukins and proteases that enhance the influx of monocytes and lymphocytes, thereby promoting the progression of atherosclerotic lesions [2] . The role of the immune system in atherosclerosis has received considerable interest in recent years; however, sufficient knowledge to justify the immunomodulatory mechanisms has not yet been obtained.
In recent years, a novel subtype of T cell, called the regulatory T cells (Tregs), have been shown to play a critical role in the development of atherosclerosis. Natural Treg cells, characterized by the expression of CD4, CD25 and the transcriptional factor Foxp3 (forkhead-wingedhelix transcription factor), have the capacity to the maintenance of immunological tolerance against self and non-self antigens and prevent the development of various immunoinflammatory diseases [4] [5] [6] [7] . Several preliminary studies have shown this type of regulatory T cell inhibited the development and progression of atherosclerosis.
Tregs on the adaptive immune system and on CD4 + T cells in particular have been well documented [1, 2] . But their effects on innate immune are less well known. The macrophage, one of the principal effector cell of innate immunity, play a critical role in both innate and adaptive immunity through their ability to recognize pathogens and/or "danger signals" via Toll-like receptors (TLRs) and other pattern-recognition receptors; through their effector mechanisms, including phagocytosis, nitric oxide production, and killing of bacteria; and through their ability to produce a wide array of cytokines and chemokines. Recently, a family of TLRs has been identified as a key recognition component of innateimmunity [8, 9] . TLRs are originally identified as receptors that activate host defenses in response to microbialderived ligands such as Gram-negative bacterial lipopolysaccharide (LPS) [10] , they are now increasingly documented to respond to endogenous modified self, such as modified and/or oxidized low-density lipoprotein (OxLDL).There are growing evidences showing the contribution of the TLR-signaling pathway to initiation and progression of atherosclerosis [11, 12] In the advanced atherosclerotic lesions in human, TLR1, TLR2, and TLR4 were detected in not only infiltrating macrophages but also vascular cells such as endothelial cells and vascular smooth muscle cells, and they might contribute to plaque activation [13, 14] . Because macrophages are essential partners in innate and acquired immunity and as such play a variety of roles in atherosclerotic plaque development and its clinical sequelae [3] , so understanding the mechanisms behind the homeostatic control of macrophage function is, therefore, of fundamental importance. Thus, this study was designed to evaluate the effects of Tregs on Ox-LDL-activated macrophages and its possible mechanisms from TLRs-dependent pathway.
Materials and Methods
Animals
All C57BL/6 background mice were obtained from Peking University. They were housed in the specific pathogen-free conditions in our animal facility and administered food and water ad libitum. The investigation conforms to the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH Publication No. 85-23, revised 1996) and is approved by the Ethics Committee of Tongji Medical College, Huazhong University of Science and Technology.
Preparation of LDL and copper-oxidized LDL Blood for lipoprotein isolation was collected in EDTA (1 mg/mL) from normal lipidemic donors after 12 hours of fasting. LDL (density=1.03 to 1.063 g/L) was isolated from the plasma after density adjustment with KBr, by preparative ultracentrifugation at 5000 rpm/min for 22 hours, using type 50 rotor. They were dialyzed against PBS containing 0.3 mM EDTA, sterilized by filtration through a 0.22-mm filter, and stored under nitrogen gas at 4 °C. Protein content was determined by the method of Lowry et al. Copper oxidation of LDL was performed by incubation of post-dialyzed LDL (1 mg of protein/mL in EDTA-free PBS) with copper sulfate (10 mM) for 24 hours at 37°C
. Lipoprotein oxidation was confirmed by analysis of thiobarbituric acid-reactive substances [15] .
Cell isolation and purification
For cells isolation, groups of 8-to 12-week-old male mice were used for all experiments. Murine peritoneal macrophages were harvested after intraperitoneal injection (5 ml per mouse) of phosphate-buffered saline (PBS). After centrifugation at 1000 × g for 5 minutes, the cells were resuspended into complete RPMI 1640 medium containing 10% fetal bovine serum (FBS) and 100 U/ml of penicillin/streptomycin•Cthen adjusted to the concentration of 1×10 ) for 40 hours in the presence of anti-CD3 antibody (50 ng/ml, eBioscience, California, USA) [16] , then T cells were depleted by using CD2-microbeads (Miltenyi Biotec), and the purified macrophages were stimulated with oxLDL (50 µg/ml). After 48 hours, lipid-loaden macrophages were harvested and supernatants were collected for further experiments.
Phenotypic Analysis
After the incubation period, macrophages from different groups were incubated with human leukocyte antigen DR (HLA DR)-PE antibody solution and CD86-PE antibody solution (eBioscience, USA) at 4 °C for 0.5 h, respectively. Then we washed them two times with PBS which contains 2% bovine serum albumin (BSA) and 0.1% NaN 3 . For isotype control, PEconjugated human anti-IgG 1 antibodies (eBioscience, USA) were used. Cells were resuspended in 500 µL PBS with 1% paraformal-dehyde and immediately processed using a FACS LSR α (Becton Dickinson, USA). After correction for unspecific binding (isotype control), the percentage of positive cells were analyzed by the Cell Quest program (Becton Dickinson, USA).
Measurement of NO production
The amount of nitrite produced by the mouse macrophage was indicated by the amount of accumulation of NO2-that was measured in the above cell culture supernatant from different groups using the Greiss reagent, as described previously [17] . Briefly, equal volumes of culture supernatant and Greiss reagent (100 µl) were mixed for 10 min at room temperature. Absorbance at 540 λ was measured with a Labsystems Multiscan Ascent assay plate reader. A solution of NO2 was used to construct a standard curve.
ELISA assay for cytokines
The peritoneal macrophages were collected and coculture experiments were performed as described in the previous section. Supernatants were collected after 48 hours exposure to oxLDL, and kept frozen at -80 °C until the cytokine levels (TNF-α, MCP-I, MMP-9, IL-10, and TGF-β) were determined by ELISA assays according to the manufacturer's instructions. Each sample was tested for each cytokine in triplicate.
RT-PCR and real-time PCR
Total RNA from macrophages was isolated using Trizol reagent (Invitrogen) according to manufacturer's instruction. PCR was performed after cDNA synthesis using Platinum PCR SuperMix (Invitrogen, Carlsbad, CA) and primer pairs specific for inducible NO synthase (iNOS) and GAPDH. Real-time PCR was performed on GAPDH, TLR2 and TLR4. Quantitative realtime PCR was carried out with ABI PRISM 7900 Sequence Detector system (Applied Biosystem, Foster City, CA). GAPDH was used as endogenous control. PCR reaction mixture contained the SYBR Green I (Takara Biotechnology), cDNA, and the primers. Relative gene expression level (the amount of target, normalized to endogenous control gene) was calculated using the comparative Ct method formula 2-ΔΔCt. The sequences of primers for PCR were used: GAPDH (5'-CCA TCA CCA TCT TCC AGG AGC AGC GAG-3' and 5'-CAC AGT CTT CTG GGT GGC AGT GAT-3'), iNOS (5'-CCC TTC CGA AGT TTC TGG CAG CAG C-3' and 5'-GGC TGT CAG AGC CTC GTG GCT TTG G-3'), TLR2 (5'-CCA GAC ACT GGG GGT AAC ATC -3' and 5'-CGG ATC GAC TTT AGA CTT TGG G-3'), TLR4 (5'-GCC TTT CAG GGA ATT AAG CTC C-3' and 5'-AGA TCA ACC GAT GGA CGT GGA CGT GAT A -3').
Electrophoretic Mobility Shift Assay
Electrophoretic mobility shift assay (EMSA) was performed by a nonradioactive method (Pierce, USA) as described previously. After 48 hours incubation with oxLDL, nuclear proteins were extracted with NE-PER nuclear and cytoplasmic extraction reagents (Pierce, USA) according to the manufacturer's instructions, and EMSA was performed with a LightShift chemiluminescent EMSA kit (Pierce, USA). For EMSA, the binding reactions were performed for 20 minutes in 10 mmol/L Tris-HCl (pH 7.5), 50mmol/L KCl, 5 mmol/L MgCl 2 , 1 mmol/L dithiothreitol, 50 ng/µL poly (dI-dC), 0.05% NP-40, 2.5% glycerol, biotin 3-end-labeled double-stranded oligonucleotide, and nuclear protein extract (30 µg/well). Samples were electrophoresed on a native polyacrylamide gel and then transferred to a nylon membrane. The biotin end-labeled DNA was detected by chemiluminescence. The double-stranded NFκB oligonucleotide where the 3' end of the probe was labeled with biotin contained: 5'-AGT TGA GGG GAC TTT CCC AGC C-3'.
Statistical analyses
Results are shown as mean±SEM of at least three independent experiments. The significance of differences was estimated by ANOVA followed by Student-Newmann-Keuls multiple comparison tests. P•ƒ0.05 was considered significant. All statistical analyses were performed with SPSS software (version 11.0, SPSS Inc., Chicago, IL). HLA DR expression compared with that in no T and in CD25+ (Fig. 1) .
Results
Effects of Tregs on the expression of immune phenotypic markers of ox-LDL activated macrophage
Tregs Inhibit NO production in oxLDL-stimulated macrophage
We initially examined the inhibitory effects of the Tregs on the production of the inflammatory mediators, NO. Therefore, we examined iNOS production in each of the three oxLDL-exposed macrophage populations. First, we measured the accumulation of NO respectively.) (Fig. 2) .
Tregs reduce iNOS expression in oxLDLstimulated macrophage
RNA was isolated from the three populations of activated macrophage 4 h after stimulation and analyzed by RT-PCR. We examined iNOS mRNA in each of the three populations. Consistent with the protein activity data above, iNOS levels were reduced in Treg-treated cultures (0.89±0.3) compared with that in no T (3.52±0.3) and CD25-cultures (3.16±0.7) (Fig. 3) . This indicates that the reduced expression of iNOS due to Treg treatment was responsible for the inhibition of NO production.
Tregs inhibit the proinflammatory response in oxLDL-induced macrophage
To determine if Tregs modulate the capacity of oxLDL-induced inflammatory response in macrophage, the levels of proinflammatory cytokines (TNF-α, MCP-I, MMP-9, TGF-β, and IL-10) were determined by ELISA assay. Our data show that, after coculture with Tregs, macrophages displayed a decrease in their capacity to produce proinflammatory cytokines/ chemokines (TNF-α, MCP-1, and MMP-9) (Fig. 4A) . In contrast, the production of the antiinflammatory cytokines TGF-β and IL-10 was enhanced (Fig. 4B) in Treg-treated cultures. As a control, CD4 + CD25 + T-treated cultures displayed an increased production of proinflammatory and a less production of antiinflammatory cytokines/chemokines. Results collectively indicated rather than inhibiting proinflammatory response, Tregs could induce an antiinflammatory response in oxLDL-induced macrophage foam cell formation.
Effects of Tregs on NF-κB expression in oxLDLinduced macrophage
NF-κB is a ubiquitous transcription factor that regulates expression of proinflammatory and antiapoptotic genes and is thought to play an important role in driving the inflammatory response [18] . Therefore, we examined NF-κB activity in macrophages cocultured with or without Fig. 4 . Tregs Inhibit the Proinflammatory Response of Macrophages to oxLDL. Macrophages(3-4×106/well) were cultured alone (no T), with Tregs (CD25+, 5×105/well), or CD4+CD25-T cells (CD25-, 5×105/well) for 40 hours in the presence of anti-CD3 antibody (50ng/ml), after which T cells were depleted and the different cultures were stimulated for 48 hours with oxLDL (50µg/ml). After the incubation period, cytokine/chemokine production was measured by ELISA (TNF-α, MCP-1, MMP-9, IL-10, and TGF-β). The average production of six independent experiments ±SEM of proinflammatory (A) and antiinflammatory (B) cytokines/chemokines are shown for the three cultures. (# is indicated for CD25+ vs no T; * is indicated for CD25+ vs CD25-; + is indicated for CD25-vs no T. #:p<0.05; ##:p<0.01; ###:p<0.001; *: p<0.05; **: p<0.01; ***: p<0.001; +: p<0.05.). 
Effects of Tregs on TLRs expression in oxLDLinduced macrophage
To explore whether TLRs involved in Tregmodulating macrophages inflammatory response to oxLDL, TLR2 and TLR4 mRNA were measured by realtime PCR. Our data have shown that compared with untreated cultures (no T) and CD4 + CD25 + T-treated cultures (CD25 + ), the expression of TLR4 mRNA was decreased, but without significant difference, indicating that the decreased proinflammatory cytokine response to oxLDL of Treg-modulated macrophages was not explained by a decreased expression of TLR4 after Treg contact. However, TLR2 mRNA expression had a clear decrease in CD4 + CD25 + T-treated cultures (Fig. 6,  P<0.05) .
Discussion
In the current study, we provide evidence that CD4 + CD25 + regulatory T cells can inhibit CD86 and HLA DR expression and the pro-inflammatory properties of OxLDL induced-macrophages (decreased NO production and iNOS expression, down-regulated proinflammatory cytokine/chemokine production) and steer macrophage Monocyte and macrophage phenotypic diversity is important in atherogenesis. Macrophages are an extremely heterogeneous lineage displaying a range of both pro-and antiinflammatory functions [19] . Two extremes in the spectrum of macrophage function are represented by the "classically"activated (or M1) and the alternative (or M2) phenotypes [20] [21] [22] [23] . The M1 phenotype is typified by IFN-γ-primed macrophages and is characterized by increased MHC class II, IL-12, and inducible nitric oxide synthase (NOS2) expression. M2 macrophages are characterized by decreased expression of NOS2, MHC class II, and IL-12, but elevated expression of antiinflammatory cytokines such as IL-10. The M2 phenotype is promoted by Th2 cytokines such as IL-4 and IL-13. Generally, M2 macrophages are considered antiinflamatory cells, whereas M1 macrophages are proinflammatory [23, 24] . The signaling pathways that regulate these phenotypes in vivo are not well understood. Our data showed that with oxLDL challenge, the Treg-modulated macrophages display features of AAM subsets: These cells have decreased NO production and iNOS expression, decreased HLA-DR and CD86 expression, and down-regulated proinflammatory cytokine/chemokine production. Tregs can inhibit the pro-inflammatory properties of macrophages and steer macrophage differentiation toward an anti-inflammatory cytokine producing phenotype compared with untreated macrophages, indicating that rather than inducing a general cytokine down-regulation in macrophages, Tregs shift the balance fom a proinflammatory toward an antiinflammatory cytokine profile. A paper from M. M. Tiemessen's group reported similar findings in CD4 + CD25 + Foxp3 + regulatory T cells induce alternative activation of human monocytes/ macrophages [16] . Token together, this emerging evidence suggests that Treg modulating the polarization of macrophage a switch to an M2 phenotype may limit the innate immune response and be required for the resolution of inflammation.
Our study further demonstrated that Treg-mediated suppression of the monocyte response to oxLDL is accompanied by a reduction in the up-regulation of NF-κB activity. NF-κB activation is required for proinflammatory cytokine gene expression. The decreased NF-κB activation may well be due to the increased levels of IL-10 and TGF-β in the Treg-monocyte culture, because it has been shown that both IL-10 and TGF-β can suppress NF-κB activation [25] . Moreover, IL-10-induced suppression of NF-κB activation is also found in tumor-associated macrophages, which have an alternatively activated phenotype [26] . Furthermore, blocking NF-κB activation in classically activated macrophages results in a decreased proinflammatory response and reduced expression of costimulatory markers, whereas the phagocytic capacity remains intact and bacterial killing is enhanced [18] . More recent reports have shown NF-κB has tissue-specific roles in inflammation; although NF-κB activation in epithelial cells is required to drive the inflammatory response, NF-κB activity in macrophages has an opposing role in the resolution of inflammation.
Macrophages are the predominant participants in innate immune responses in atherosclerosis via protein receptors. In particular, the members of the toll-like receptor (TLR) family play a critical role in the inflammatory components of atherosclerosis. So far 11 TLRs have been found in mammals and a great number of exogenous and endogenous ligands has been identified. Their activation by various ligands triggers a signaling cascade leading to initiate the activation of NF-κB, resulting in the transcription of a variety of genes involved in the inflammatory and proliferative responses of cells critical to atherogenesis [13] and ultimately leading to the synthesis and release of antimicrobial peptides and inflammatory cytokines that provide a critical link to adaptive immunity [8, 27] .
Several reports have documented the expression of TLRs, in particular TLR4, TLR1, TLR2, and to a lesser extent TLR5 in both human plaques and murine models of atherosclerosis [14, 27] , where they appear to be mainly localized to macrophages and endothelial cells. In these cells, both TLR2 and TLR4 frequently colocalized with NF-κB [27] , a transcription factor that induces TLR expression but also mediates the downstream signaling of TLR on ligand engagement. Similarly, the presence of NF-κB p65 was also observed in TLR positive macrophages. This suggests that the TLR-NF-κB pathway is activated in the lesion. Our data showed that Treg-mediated suppression of the monocyte response to oxLDL was reflected by a reduction in the up-regulation of NF-κB activity accompanied by a decreased expression of TLR2 but not TLR4 at the transcriptional level, indicating that TLR2-NF-κB signaling pathway may play critical role in CD4 + CD25 + Foxp3 + regulatory T cells modulated macrophage functions. This may be partly explained by that the motif pathogen-associated molecular patterns such as lipopolysaccharide (LPS) are recognized by TLR-4 [28] , and those such as lipoteichoic acid (LTA), diacylated and triacylated lipopeptides are recognized mainly by TLR-2 [29] . Recent studies have shown that CD16 + monocytes express higher levels of TLR-2 and produce larger amounts of TNFá in response to the TLR-2-specific bacterial lipopeptide when compared with CD16 monocytes, suggesting the relevance of TLR-2 to CD16 + monocyte activation [30] . Interestingly, the majority of CD14 + CD16 + monocytes seem anti-inflammatory, as they produce the cytokine IL-10 in response to bacterial LPS. Conversely, the smaller CD14lowCD16 + population seems proinflammatory because it produces proinflammatory mediators in response to LPS and shows an increase in plasma levels during inflammatory conditions, including atherosclerosis [19] .
